Clinical Trials Directory

Trials / Conditions / Stage III Gastric Cancer

Stage III Gastric Cancer

14 registered clinical trials studyying Stage III Gastric Cancer — 1 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingMegestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction A
NCT07391826
The First Affiliated Hospital with Nanjing Medical UniversityPhase 2
UnknownImmunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer
NCT05253716
Jinling Hospital, ChinaN/A
Active Not RecruitingTAS102 in Combination With NAL-IRI in Advanced GI Cancers
NCT03368963
Emory UniversityPhase 1 / Phase 2
CompletedHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
NCT03154190
Stanford UniversityN/A
CompletedVaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer
NCT01191684
City of Hope Medical CenterPhase 1
CompletedSaracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Canc
NCT00607594
National Cancer Institute (NCI)Phase 2
CompletedOxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydroch
NCT01561014
Wake Forest University Health SciencesPhase 1
CompletedS0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer
NCT00103324
National Cancer Institute (NCI)Phase 2
CompletedAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00089362
National Cancer Institute (NCI)Phase 1
TerminatedEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
NCT00087191
National Cancer Institute (NCI)N/A
CompletedIrinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the St
NCT00062374
National Cancer Institute (NCI)Phase 2
CompletedVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
NCT00028496
National Cancer Institute (NCI)Phase 1
CompletedBryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer
NCT00006389
National Cancer Institute (NCI)Phase 2
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1